Why the study?
Does pyrrolidine dithiocarbamate reduce Coxsackievirus B3 replication in infected HeLa cells?
Population
HeLa cells (American Type Culture Collection) infected with Coxsackievirus B3 (Kandolf strain)
Comparison
Pyrrolidine dithiocarbamate at various… vs CVB3-infected HeLa cells without PDTC treatment
Design
Preclinical
Authors
Loading...
PDTC inhibition of CVB3 in vitro is hypothesis-generating; in vivo efficacy for viral myocarditis remains untested.
Does pyrrolidine dithiocarbamate reduce Coxsackievirus B3 replication in infected HeLa cells?
PDTC potently inhibits Coxsackievirus B3 replication in vitro, likely through modulation of the ubiquitin-proteasome pathway, suggesting potential as an antiviral strategy for viral myocarditis.
Si et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: